[go: up one dir, main page]

AU2002212436A1 - Quinazoline derivatives - Google Patents

Quinazoline derivatives

Info

Publication number
AU2002212436A1
AU2002212436A1 AU2002212436A AU1243602A AU2002212436A1 AU 2002212436 A1 AU2002212436 A1 AU 2002212436A1 AU 2002212436 A AU2002212436 A AU 2002212436A AU 1243602 A AU1243602 A AU 1243602A AU 2002212436 A1 AU2002212436 A1 AU 2002212436A1
Authority
AU
Australia
Prior art keywords
quinazoline derivatives
quinazoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212436A
Inventor
Patrick Ple
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2002212436A1 publication Critical patent/AU2002212436A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2002212436A 2000-10-25 2001-10-19 Quinazoline derivatives Abandoned AU2002212436A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00402962 2000-10-25
EP00402962 2000-10-25
PCT/GB2001/004674 WO2002034744A1 (en) 2000-10-25 2001-10-19 Quinazoline derivatives

Publications (1)

Publication Number Publication Date
AU2002212436A1 true AU2002212436A1 (en) 2002-05-06

Family

ID=8173918

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212436A Abandoned AU2002212436A1 (en) 2000-10-25 2001-10-19 Quinazoline derivatives

Country Status (5)

Country Link
US (1) US20040063733A1 (en)
EP (1) EP1332141A1 (en)
JP (1) JP2004512335A (en)
AU (1) AU2002212436A1 (en)
WO (1) WO2002034744A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001278609B2 (en) 2000-08-21 2005-04-14 Astrazeneca Ab Quinazoline derivatives
JP2004511479A (en) 2000-10-13 2004-04-15 アストラゼネカ アクチボラグ Quinazoline derivatives
EP1330444B1 (en) 2000-11-01 2011-03-23 Millennium Pharmaceuticals, Inc. Nitrogenous heterocyclic compounds and process for making them
WO2002085895A1 (en) 2001-04-19 2002-10-31 Astrazeneca Ab Quinazoline derivatives
ATE341545T1 (en) 2001-07-16 2006-10-15 Astrazeneca Ab QUINOLINE DERIVATIVES AND THEIR USE AS TYROSINE KINASE INHIBITORS
US6924285B2 (en) 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
WO2004006846A2 (en) 2002-07-15 2004-01-22 Exelixis, Inc. Receptor-type kinase modulators and methods of use
WO2004041829A1 (en) 2002-11-04 2004-05-21 Astrazeneca Ab Quinazoline derivatives as src tyrosine kinase inhibitors
GB0318422D0 (en) * 2003-08-06 2003-09-10 Astrazeneca Ab Chemical compounds
ATE395346T1 (en) 2003-09-16 2008-05-15 Astrazeneca Ab QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS
GB0322409D0 (en) 2003-09-25 2003-10-29 Astrazeneca Ab Quinazoline derivatives
CA2744997A1 (en) 2003-09-26 2005-04-07 Exelixis, Inc. C-met modulators and method of use
GB0326459D0 (en) 2003-11-13 2003-12-17 Astrazeneca Ab Quinazoline derivatives
ES2315834T3 (en) 2004-02-03 2009-04-01 Astrazeneca Ab DERIVATIVES OF QUINAZOLINA.
AU2005223610B2 (en) * 2004-03-23 2008-05-29 Banyu Pharmaceutical Co., Ltd. Substituted quinazoline or pyridopyrimidine derivative
JP4659403B2 (en) * 2004-07-15 2011-03-30 富士フイルム株式会社 Phthalocyanine compound, ink, ink jet recording method, and image forming method
EP1921070A1 (en) 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclic heterocycles, medicaments comprising them, their use and process for their preparation
EA200901041A1 (en) 2007-02-06 2010-02-26 Бёрингер Ингельхайм Интернациональ Гмбх BICYCLIC HETEROCYCLES CONTAINING THESE COMPOUNDS MEDICINES, THEIR APPLICATION AND METHOD OF OBTAINING THEM
PL2245026T3 (en) 2008-02-07 2013-01-31 Boehringer Ingelheim Int Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production
ES2444128T3 (en) 2008-05-13 2014-02-24 Astrazeneca Ab New SAL-554
JP5539351B2 (en) 2008-08-08 2014-07-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cyclohexyloxy-substituted heterocycles, medicaments containing these compounds, and methods for producing them
KR101733773B1 (en) 2009-01-16 2017-05-10 엑셀리시스, 인코포레이티드 The end of N- (4 - {[6,7-bis (methyloxy) quinolin-4-yl] oxy} phenyl) -N '- (4-fluorophenyl) cyclopropane-1,1-dicarboxamide Acid salts and their crystalline forms
UA108618C2 (en) 2009-08-07 2015-05-25 APPLICATION OF C-MET-MODULATORS IN COMBINATION WITH THEMOSOLOMID AND / OR RADIATION THERAPY FOR CANCER TREATMENT
US9139590B2 (en) 2011-02-04 2015-09-22 Duquesne University Of The Holy Spirit Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
CA2905242C (en) 2013-03-15 2016-11-29 Pfizer Inc. Indole compounds that activate ampk
US11920164B2 (en) 2014-07-30 2024-03-05 Yeda Research And Development Co. Ltd. Media for culturing naive human pluripotent stem cells
EP3914698B1 (en) 2019-01-23 2024-12-11 Yeda Research and Development Co. Ltd Culture media for pluripotent stem cells

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9016A (en) * 1852-06-15 Improvement in machines for making cigars
US20642A (en) * 1858-06-22 Machine eor setting spokes in hubs
US77085A (en) * 1868-04-21 parker
US23141A (en) * 1859-03-01 Improvement in the manufacture of precipitated sulphur
US39145A (en) * 1863-07-07 Improvement in balances
US50370A (en) * 1865-10-10 Improved composition for friction-matches
US602851A (en) * 1898-04-26 Grannis
US47212A (en) * 1865-04-11 Improvement in lanterns
US2434A (en) * 1842-01-24 Improvement in the mode of propelling boats by means of endless chains of paddles
US21594A (en) * 1858-09-28 Cobn-shelleb
US3069A (en) * 1843-05-02 Improvement in plows
US15758A (en) * 1856-09-23 Mode of adjusting- the slats of window-blinds
US2295387A (en) * 1940-07-31 1942-09-08 Rca Corp Indicator
US5710158A (en) * 1991-05-10 1998-01-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
GB9323290D0 (en) * 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
GB9514265D0 (en) * 1995-07-13 1995-09-13 Wellcome Found Hetrocyclic compounds
EP0837063A1 (en) * 1996-10-17 1998-04-22 Pfizer Inc. 4-Aminoquinazoline derivatives

Also Published As

Publication number Publication date
WO2002034744A1 (en) 2002-05-02
US20040063733A1 (en) 2004-04-01
JP2004512335A (en) 2004-04-22
EP1332141A1 (en) 2003-08-06

Similar Documents

Publication Publication Date Title
AU2002221047A1 (en) Quinazolinone derivatives
AU2002212436A1 (en) Quinazoline derivatives
IL154131A0 (en) Quinazoline derivatives
AU2001280099A1 (en) 4-acylaminopyrazole derivatives
AU2001230584A1 (en) 1h-imidazopyridine derivatives
AUPR975601A0 (en) Quinazolinone derivatives
AU2960599A (en) Quinazoline derivatives
AU2001230537A1 (en) Pyridoxazine derivatives
AU2002352444A1 (en) Quinazolinedione derivatives
AU2001281802A1 (en) 6-phenylpyrrolopyrimidinedione derivatives
AU2001278790A1 (en) 1h-imidazopyridine derivatives
AU2001292137A1 (en) Quinazoline derivatives
AU7419300A (en) Quinazolinones
AU2002213978A1 (en) Substituted C-cyclohexylmethylamine derivatives
AU2002212301A1 (en) Diazacycloalkanedione derivatives
AU2002212959A1 (en) Cycloalkylfluorosulfonamide derivatives
AU7654800A (en) Quinazolinones
AU2002215212A1 (en) 1-methylcarbapenem derivatives
AU2001254661A1 (en) Aminosulfonylbiphenyl derivatives
AU2001230565A1 (en) Perfluoroisopropylbenzene derivatives
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2001234313A1 (en) Novel phenylheteroalkylamine derivatives
AU2001242772A1 (en) 3-substituted-4-pyrimidone derivatives
AU2002212263A1 (en) Substituted 5-amino-1-pentene-3-ol derivatives
AU2002221632A1 (en) 5-amino-1-pentene-3-ol substituted derivatives